Hydroa vacciniforme-like lymphoma: Difference between revisions

Jump to navigation Jump to search
Line 8: Line 8:


==Historical Perspective==
==Historical Perspective==
Hydro vacciniforme-like lymphoma reports date back from 1986,<ref name="pmid3490832">{{cite journal| author=Oono T, Arata J, Masuda T, Ohtsuki Y| title=Coexistence of hydroa vacciniforme and malignant lymphoma. | journal=Arch Dermatol | year= 1986 | volume= 122 | issue= 11 | pages= 1306-9 | pmid=3490832 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3490832  }} </ref> although only since 2008 the WHO recognize the HVLL a separate entity from the Hydroa vacciniforme and classified it under <i>"EBV positive T-cell lymphoproliferative disorders of childhood".</i>
Hydroa vacciniforme-like lymphoma reports date back from 1986,<ref name="pmid3490832">{{cite journal| author=Oono T, Arata J, Masuda T, Ohtsuki Y| title=Coexistence of hydroa vacciniforme and malignant lymphoma. | journal=Arch Dermatol | year= 1986 | volume= 122 | issue= 11 | pages= 1306-9 | pmid=3490832 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3490832  }} </ref> although only since 2008 the WHO recognize the HVLL as a separate entity from the Hydroa vacciniforme and classified it under <i>"EBV positive T-cell lymphoproliferative disorders of childhood".<ref name=Swerdlow>{{cite book | last = Swerdlow | first = Steven | title = WHO classification of tumours of haematopoietic and lymphoid tissues | publisher = International Agency for Research on Cancer | location = Lyon, France | year = 2008 | isbn = 9789283224310 }}</ref></i>


==Classification==
==Classification==

Revision as of 19:11, 24 February 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alberto Plate [2]

Synonyms and keywords: Hydroa-like CTCL, HVLL

Overview

Hydroa vacciniforme-like lymphoma is a EBV-positive peripheral T-cell lymphoma (Non-Hodgkin's lymphoma), that affects primarily pediatric patients and has a bad prognosis.[1] It is associated with photosensitivity and insect bites.[2] Clinically, it manifests with vacciniform vesicles, necrotic ulcers and scars.[3]

Historical Perspective

Hydroa vacciniforme-like lymphoma reports date back from 1986,[4] although only since 2008 the WHO recognize the HVLL as a separate entity from the Hydroa vacciniforme and classified it under "EBV positive T-cell lymphoproliferative disorders of childhood".[2]

Classification

Pathophysiology

Causes

Differential Diagnosis

Epidemiology and Demographics

Hydroa vacciniforme-like lymphoma occurs mainly in the pediatric population from South America, Central America and Asia.[5] Although rare, it may present in adult population.[6]

Risk Factors

Natural History, Complications, and Prognosis

Diagnosis

History and Symptoms

Edema, blisters, ulcers, crusts and scars are evidenced in face and extremities of patients with Hydroa vacciniforme-like lymphomas. The mentioned lesions may or may not appear in sunlight exposed areas.[7] Patients may present with typical B symptoms,[8] which in some cases, are preceded by periorbtal swelling.[9]

Treatment

References

  1. Barrionuevo C, Anderson VM, Zevallos-Giampietri E, Zaharia M, Misad O, Bravo F; et al. (2002). "Hydroa-like cutaneous T-cell lymphoma: a clinicopathologic and molecular genetic study of 16 pediatric cases from Peru". Appl Immunohistochem Mol Morphol. 10 (1): 7–14. PMID 11893040.
  2. 2.0 2.1 Swerdlow, Steven (2008). WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon, France: International Agency for Research on Cancer. ISBN 9789283224310.
  3. "Hydroa vacciniforme-like lymphoma: a case report and literature review" (PDF).
  4. Oono T, Arata J, Masuda T, Ohtsuki Y (1986). "Coexistence of hydroa vacciniforme and malignant lymphoma". Arch Dermatol. 122 (11): 1306–9. PMID 3490832.
  5. Quintanilla-Martinez L, Ridaura C, Nagl F, Sáez-de-Ocariz M, Durán-McKinster C, Ruiz-Maldonado R; et al. (2013). "Hydroa vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma". Blood. 122 (18): 3101–10. doi:10.1182/blood-2013-05-502203. PMID 23982171.
  6. Wang RC, Chang ST, Hsieh YC, Huang WT, Hsu JD, Tseng CE; et al. (2014). "Spectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan". Int J Clin Exp Pathol. 7 (5): 2430–7. PMC 4069894. PMID 24966953.
  7. Doeden K, Molina-Kirsch H, Perez E, Warnke R, Sundram U (2008). "Hydroa-like lymphoma with CD56 expression". J Cutan Pathol. 35 (5): 488–94. doi:10.1111/j.1600-0560.2007.00836.x. PMID 17976208.
  8. Boddu D, George R, Nair S, Bindra M, G Mathew L (2014). "Hydroa Vacciniforme-Like Lymphoma: A Case Report From India". J Pediatr Hematol Oncol. doi:10.1097/MPH.0000000000000221. PMID 25072366.
  9. Plaza JA, Sangueza M (2015). "Hydroa vacciniforme-like lymphoma with primarily periorbital swelling: 7 cases of an atypical clinical manifestation of this rare cutaneous T-cell lymphoma". Am J Dermatopathol. 37 (1): 20–5. doi:10.1097/DAD.0000000000000158. PMID 25162933.


Template:WikiDoc Sources